TIDMFUM

RNS Number : 1400K

Futura Medical PLC

06 April 2018

 
 For immediate release   6 April 2018

Futura Medical plc

("Futura" or the "Company")

Notice of AGM

Futura Medical plc (AIM: FUM), the innovative healthcare company focused on advanced transdermal technology, announces that its notice of Annual General Meeting ("AGM"), including Explanatory Notes and Form of Proxy, has today been posted to shareholders. The AGM will be held at 4.30pm on 13 June 2018 at the offices of Buchanan, 107 Cheapside, London EC2V 6DN.

Futura's annual report and accounts for the year ended 31 December 2017 (the "Annual Report") is available to shareholders as an electronic communication pursuant to the Companies Act 2006 and is now available at the Company's website www.futuramedical.com, along with the notice of AGM.

Copies of the Annual Report have today been posted to shareholders who have opted out of receiving electronic communications. Shareholders who would like to attend the AGM are invited to contact Buchanan on 020 7466 5000 or email tillya@buchanan.uk.com.

For any further information please contact:

 
 Futura Medical plc 
 James Barder, Chief Executive                                         Tel: +44 (0)1483 
  Angela Hildreth, Finance Director                                             685 670 
  and COO 
 mail to: james.barder@futuramedical.com                          www.futuramedical.com 
              angela.hildreth@futuramedical.com 
 N+1 Singer (Nominated Adviser 
  and Broker) 
 Aubrey Powell / Liz Yong                                           Tel:+44 (0) 20 7496 
                                                                                   3000 
 
 For media enquiries please 
  contact: 
 Buchanan 
 Mark Court / Sophie Wills /                                        Tel: +44 (0)20 7466 
  Stephanie Watson / Tilly Abraham                                                 5000

Notes to Editors

Futura Medical plc

Futura Medical is a pharmaceutical group that develops innovative products for consumer healthcare. The Company is developing a portfolio of products and its strategy is to license their manufacture and distribution to major pharmaceutical and healthcare groups.

Futura is based in Guildford, Surrey, and its shares trade on the AIM market of the London Stock Exchange.

www.futuramedical.com

This information is provided by RNS

The company news service from the London Stock Exchange

END

NOAUNAARWUASRAR

(END) Dow Jones Newswires

April 06, 2018 07:13 ET (11:13 GMT)

Futura Medical (LSE:FUM)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Futura Medical Charts.
Futura Medical (LSE:FUM)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Futura Medical Charts.